Faculty Profiles - MARUYAMA, Shoichi

Papers - MARUYAMA, Shoichi

Division display 21 - 40 of about 410 ／ All the affair displays >>

Urinary presepsin is a novel biomarker capable of directly assessing monocyte/macrophage infiltration in kidney diseases Open Access

Niwa, S; Tanaka, A; Furuhashi, K; Hattori, K; Onogi, C; Sunohara, K; Owaki, A; Kato, A; Kawazoe, T; Watanabe, Y; Koshi-Ito, E; Kato, N; Kosugi, T; Maruyama, S

SCIENTIFIC REPORTS Vol. 14 ( 1 ) page： 30088 2024.12

Association between alpha blocker use and the risk of fractures in patients with chronic kidney disease: a cohort study Open Access

Sunohara, K; Onogi, C; Tanaka, A; Furuhashi, K; Matsumoto, J; Hattori, K; Owaki, A; Kato, A; Kawazoe, T; Watanabe, Y; Koshi-Ito, E; Maruyama, S

BMC NEPHROLOGY Vol. 25 ( 1 ) page： 442 2024.12

Effect of tonsillectomy combined with steroid pulse therapy upon IgA nephropathy depending on proteinuria status at diagnosis: a nationwide multicenter cohort study in Japan Open Access

Komatsu, H; Fujimoto, S; Sato, Y; Yasuda, T; Yasuda, Y; Matsuzaki, K; Hirano, K; Kawamura, T; Yokoo, T; Suzuki, Y; Maruyama, S

CLINICAL AND EXPERIMENTAL NEPHROLOGY Vol. 28 ( 12 ) page： 1272 - 1281 2024.12

A case of non-traumatic rectus sheath hematoma in a post-kidney transplant patient undergoing catheter embolization during anticoagulation treatment for atrial fibrillation Open Access

Fujieda, K; Saito, S; Tanaka, A; Furuhashi, K; Ozeki, T; Yasuda, Y; Sano, Y; Ishida, S; Maruyama, S

CEN CASE REPORTS Vol. 13 ( 6 ) page： 528 - 533 2024.12

Associations of anaemia and iron deficiency with health-related quality of life in patients with chronic kidney disease stage G3b-5 in Japan: sub analysis of the Reach-J CKD cohort study Open Access

Okubo, R; Ohigashi, T; Kondo, M; Tsunoda, R; Kai, HRYS; Saito, C; Hoshino, J; Okada, H; Narita, I; Maruyama, S; Wada, T; Yamagata, K

BMC NEPHROLOGY Vol. 25 ( 1 ) page： 414 2024.11

Association between proteinuria and mineral metabolism disorders in chronic kidney disease: the Japan chronic kidney disease database extension (J-CKD-DB-Ex) Open Access

Shimamoto, S; Nakahara, T; Yamada, S; Nagasu, H; Kishi, S; Nakashima, N; Tsuruya, K; Okada, H; Tamura, K; Narita, I; Maruyama, S; Yano, Y; Yokoo, T; Wada, T; Wada, J; Kanda, E; Kataoka, H; Nangaku, M; Kashihara, N; Nakano, T

SCIENTIFIC REPORTS Vol. 14 ( 1 ) page： 27481 2024.11

Physical activity and renal outcome in diabetic and non-diabetic patients with chronic kidney disease stage G3b to G5 Open Access

Hoshino, J; Ohigashi, T; Tsunoda, R; Ito, Y; Kai, H; Saito, C; Okada, H; Narita, I; Wada, T; Maruyama, S; Pisoni, R; Pecoits, R; Yamagata, K

SCIENTIFIC REPORTS Vol. 14 ( 1 ) page： 26378 2024.11

Eculizumab for adult patients with atypical haemolytic-uraemic syndrome: full dataset analysis of Japanese post-marketing surveillance Open Access

Maruyama, S; Ikeda, Y; Kaname, S; Kato, N; Matsumoto, M; Ishikawa, Y; Shimono, A; Miyakawa, Y; Nangaku, M; Shibagaki, Y; Okada, H

JOURNAL OF NEPHROLOGY Vol. 37 ( 8 ) page： 2181 - 2190 2024.11

Analysis of the impact of obesity on the prognosis of IgA nephropathy according to renal function and sex

Ariyasu, Y; Torikoshi, K; Tsukamoto, T; Yasuda, T; Yasuda, Y; Matsuzaki, K; Hirano, K; Kawamura, T; Yokoo, T; Maruyama, S; Suzuki, Y; Muso, E

CLINICAL AND EXPERIMENTAL NEPHROLOGY Vol. 28 ( 11 ) page： 1155 - 1167 2024.11

Safety and Tolerability of Adipose-Derived Mesenchymal Stem Cell (ADR-001) Therapy for IgA Nephropathy Open Access

Tanaka, A; Furuhashi, K; Fujieda, K; Horinouchi, A; Maeda, K; Saito, S; Mimura, T; Saka, Y; Naruse, T; Ishimoto, T; Kato, N; Kosugi, T; Kinoshita, F; Kuwatsuka, Y; Nakai, Y; Maruyama, S

KIDNEY360 Vol. 5 ( 11 ) page： 1692 - 1705 2024.11

Correlation between a 2-week change in platelet count and clinical outcomes after the initiation of ravulizumab treatment in adult patients with atypical hemolytic uremic syndrome: post-hoc analysis of the phase III trial Open Access

Matsumoto, M; Shimono, A; Yokosawa, J; Hirose, K; Wang, ED; Maruyama, S

THROMBOSIS JOURNAL Vol. 22 ( 1 ) page： 93 2024.10

C1q Binding Ability for Prior Risk Assessment of Acute Antibody-Mediated Rejection in ABO-Incompatible Kidney Transplantation Open Access

Miwa, Y; Iwasaki, K; Murotani, K; Okada, M; Nagasaka, T; Watarai, Y; Takeda, A; Shizuku, M; Ashimine, S; Ishiyama, K; Maruyama, S; Kobayashi, T

TRANSPLANT INTERNATIONAL Vol. 37 page： 13407 2024.10

A case of late-onset organizing pneumonia following COVID-19 infection in a post-kidney transplant patient Reviewed Open Access

Fujieda, K; Saito, S; Tanaka, A; Furuhashi, K; Yasuda, Y; Sano, Y; Kato, M; Maruyama, S

CEN Case Rep Vol. 13 ( 5 ) page： 346 - 350 2024.10

Association of Proteinuria Remission and Its Timing with Kidney Outcomes in Patients with Focal Segmental Glomerulosclerosis

Kawaguchi, T; Imasawa, T; Kadomura, M; Kitamura, H; Ozeki, T; Katafuchi, R; Oka, K; Furuichi, K; Isaka, Y; Sato, H; Sugiyama, H; Maruyama, S

JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY Vol. 35 ( 10 ) 2024.10

Tiopronin-induced Membranous Nephropathy Presenting with IgG4-predominant Staining Pattern Open Access

Yamashita Jumpei, Hirakawa Yosuke, Sato Yusuke, Abe Hiroyuki, Akiyama Shin'ichi, Maruyama Shoichi, Kume Haruki, Nangaku Masaomi

Internal Medicine Vol. 64 ( 7 ) page： 1079 - 1083 2024.9

Language：English Publisher：The Japanese Society of Internal Medicine

<p>Tiopronin is a key drug used to treat cystinuria. A 41-year-old Japanese woman with cystinuria presented with eyelid edema and weight gain after the administration of tiopronin. Her serum albumin was 1.8 g/dL and her urinary protein level was 5.5 g/gCre. After cessation of tiopronin, she achieved remission of nephrotic syndrome (NS). Secondary NS due to tiopronin was evident based on the clinical course and laboratory values. A kidney biopsy showed membranous nephropathy (MN), and an immunofluorescence analysis revealed strong deposition of immunoglobulin G4 (IgG4). However, a previous case report of tiopronin-induced MN showed staining for IgG1 and IgG3. This case report suggests a novel etiology for tiopronin-induced MN. </p>

DOI： 10.2169/internalmedicine.4047-24

Cardiovascular, renal and mortality risk by the KDIGO heatmap in Japan Open Access

Maruyama, S; Tanaka, T; Akiyama, H; Hoshino, M; Inokuchi, S; Kaneko, S; Shimamoto, K; Ozaki, A

CLINICAL KIDNEY JOURNAL Vol. 17 ( 8 ) page： sfae228 2024.8

Annual trends in atypical haemolytic uremic syndrome management in Japan and factors influencing early diagnosis and treatment: a retrospective study Open Access

Tatematsu, Y; Imaizumi, T; Michihata, N; Kato, N; Kumazawa, R; Matsui, H; Fushimi, K; Yasunaga, H; Maruyama, S

SCIENTIFIC REPORTS Vol. 14 ( 1 ) page： 18265 2024.8

Changes in antibody titer after four and five doses of the SARS-CoV-2 vaccine in Japanese post-kidney transplant patients Reviewed

Fujieda, K; Tanaka, A; Kikuchi, R; Takai, N; Saito, S; Yasuda, Y; Sano, Y; Kato, M; Furuhashi, K; Maruyama, S

Ther Apher Dial Vol. 28 ( 4 ) page： 489 - 498 2024.8

Importance of education on steroid cover: a case of hyponatremia after dental extraction with local anesthesia in a patient with idiopathic hypopituitarism Reviewed Open Access

Nakamura, Y; Saito, S; Okada, N; Yamakawa, T; Maruyama, S

CEN Case Rep Vol. 13 ( 4 ) page： 308 - 309 2024.8

Association of serum magnesium levels with renal prognosis in patients with chronic kidney disease. Reviewed

Kishi S, Nakashima T, Goto T, Nagasu H, Brooks CR, Okada H, Tamura K, Nakano T, Narita I, Maruyama S, Yano Y, Yokoo T, Wada T, Wada J, Nangaku M, Kashihara N

Clin Exp Nephrol Vol. 28 ( 8 ) page： 784 - 792 2024.8

　 PREV - NEXT 　

<MARUYAMA, Shoichi>

Papers - MARUYAMA, Shoichi